subscribeSubscribe
AbbVie makes a hefty play to boost aesthetics business, paying $550M

AbbVie makes a hefty play to boost aesthetics business, paying $550M
K. Blankenship ENDPTS
10 May 2021
Share Share
Facing $50B Trial, Drugmakers Minimize Roles In Opioid Sales

Facing $50B Trial, Drugmakers Minimize Roles In Opioid Sales
LAW360
21 Apr 2021
Share Share
AbbVie may face fewer wrinkles after judge suggests a 10Y ban on a Botox rival

AbbVie may face fewer wrinkles after judge suggests a 10Y ban on a Botox rival
Ed Silverman STATNEWS
09 Jul 2020
Share Share
Drug Cos. Say Foreign Status Outs Them From Opioid Case

Drug Cos. Say Foreign Status Outs Them From Opioid Case
LAW360
21 Apr 2020
Share Share
Korea bans local sales of Medytox’s BTX drug Meditoxin

Korea bans local sales of Medytox’s BTX drug Meditoxin
By Kim Byung-wook KOREAHERALD
21 Apr 2020
Share Share
Theravance Biopharma Announces Dosing of 1st Patient in Ph 2 Allergen Study

Theravance Biopharma Announces Dosing of 1st Patient in Ph 2 Allergen Study
PR NEWSWIRE
03 Dec 2019
Share Share
Allergan adds 63 jobs to one of its Irish manufacturing sites

Allergan adds 63 jobs to one of its Irish manufacturing sites
Eric Palmer FIERCE PHARMA
29 Apr 2019
Share Share
Allergan depression treatment fails studies, shares slip

Allergan depression treatment fails studies, shares slip
M. Maddipatla REUTERS
08 Mar 2019
Share Share
Allergan’s $560M buyout deal just led to a PhIII debacle another depression drug

Allergan’s $560M buyout deal just led to a PhIII debacle another depression drug
John Carroll ENDPTS
07 Mar 2019
Share Share
Supreme Court upholds legality of patent review process

Supreme Court upholds legality of patent review process
Andrew Chung REUTERS
26 Apr 2018
Share Share